Business Highlights
July 27, 2015 at 18:12 PM EDT
___ Israel's Teva buys Allergan generic drug company for $40.5B JERUSALEM (AP) — Israel's Teva Pharmaceutical Industries Ltd. said Monday it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion, in what Israeli analysts called the largest-ever acquisition by an Israeli company.
